Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Using nerve monitoring to help protect nerves during breast cancer lymph node surgery

Official title: Feasibility of Using Intraoperative Neuromonitoring (IONM) and Bipolar Electrocautery (BE) During Axillary Lymph Node Dissection (ALND) to Provide Early Identification and Protection of the Intercostalbrachial Nerve (ICBN), Medial Branch Cutaneous Nerve (MBCN), and Their Branches

Run by University of Cincinnati · NCT07528638 · Data updated 2026-11-12

This study tests whether intraoperative nerve monitoring and bipolar electrocautery during axillary lymph node dissection can help identify and preserve nerves to reduce post-surgical neuropathic pain.

More Breast Cancer trials

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment6 (estimated)
SponsorUniversity of Cincinnati
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (Cincinnati, Ohio)
StatusRecruiting
StartedJune 29, 2026
Main results expectedJune 1, 2027
Study endsDecember 1, 2027
Registry record updatedJuly 1, 2026
Trial IDNCT07528638 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18-70 with pathologically confirmed breast cancer scheduled for ALND who have no prior axillary surgery or conditions that affect nerves.

Probably not a fit

Patients with pre-existing neuropathy, prior extensive axillary surgery, or factors that preclude safe use of neuromonitoring may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants are adults with breast cancer undergoing axillary lymph node dissection. The trial uses intraoperative neuromonitoring, including somatosensory evoked potentials and direct electrical stimulation, and replaces monopolar with bipolar cautery to help locate and protect nerves such as the ICBN and MBCN. The goal is to see if these techniques improve early nerve identification and nerve preservation during surgery. This is a feasibility/interventional assessment conducted at the University of Cincinnati with collaboration from Evokes Neuromonitoring. The study outlines parameters for reliably identifying nerves and minimizing heat spread to reduce neuropathic pain risk.

Why it matters

Potential benefit: If successful, patients may experience lower risk of neuropathic pain after ALND and related chronic discomfort.

How similar studies have gone: Preliminary data suggest nerve preservation can reduce neuropathic outcomes when nerves are locatable; this is a feasibility study building on those concepts.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients ages 18-70 years old.
2. Pathologically confirmed diagnosis of breast cancer.
3. Undergoing ALND by one of the breast surgeon Sub-Investigators on this study.

Exclusion Criteria:

1. Patients having any previous axillary surgery other than percutaneous breast biopsy and/or SLNB.
2. Prior breast radiation with neuropathy clearly developing after radiation.
3. Patients who have undergone prior chemotherapy and developed post-chemotherapy neuropathy prior to ALND.
4. Patients with any pre-existing neurological conditions affecting nerves, such as neuropathy (peripheral neuropathy, neuropathic pain or nerve injury to upper extremity).
5. Patients taking medications that are known to modify neuropathic pain (eg, gabapentin, pregabalin, duloxetine, venlafaxine, lidocaine patches, capsaicin, opioids, tramadol, NMDA receptor antagonists, clonidine, cannabis, botox).
6. Patients with prior spinal surgery or spinal pathology (cervical spinal stenosis or cervical radiculopathy).
7. Patients with limb-dysfunction.
8. Patients with demyelinating disease.
9. Patients with significant co-morbidities (clotting disorders on anticoagulation, cardiac issues, other conditions that could impact long-term follow-up).
10. Patients that present with pre-operative breast, arm or chest pain ipsilateral to anticipated ALND.
11. Patients who have had prior procedures where IONM failed intraoperatively.
12. Presence of parietal cortical lesion.

Where it's running

  • University of Cincinnati
    Cincinnati, Ohio, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.